🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07331129
Recruiting Not applicable

The Analgesic Efficacy of Ultrasound Guided Transversalis Fascia Plane Block in Inguinal Lymph Node Dissection

NCT07331129 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-12-22
Last updated
2026-01-09

Condition(s) studied

Inguinal Lymph Nodes Enlarged

Investigational drug(s) / intervention(s)

transversalis fascia plane block and surgical sit local anesthetic infiltration

transversalis fascia plane block and surgical sit local anesthetic infiltration: inguinal fascial plane block and surgical site local anesthetic infiltration

Study summary

Pain accompanying Inguinal lymph node dissection triggers a complex stress response leading to impairment of pulmonary, immunological and metabolic function. Opioids are the current gold standard drug for postoperative pain relief, however exposure to large doses lead to multiple side effects of varying significance such as nausea, vomiting, dizziness, constipation, respiratory depression, hypoventilation and sleep disordered breathing. Therefore, strategies other than opioids are recommended without sacrificing proper and effective analgesia, especially in cancer patients who are more susceptible to tolerance and addiction.

Transversalis Fascia Plane Block is used in patients undergoing various surgeries like iliac crest bone harvesting, appendicectomy, cecostomy and inguinal hernia repair, often in combination with TAP block. The initial description of TFPB was with patients in the supine position, with a linear array or curvilinear probe placed between the iliac crest and the costal margin. The external oblique, internal oblique and transversus abdominis muscles and the transversus aponeurosis are identified. The entry of the needle has to be in-plane, from the anterior aspect, and after traversing through the deep surface of the transversus abdominis muscle, local anesthetic is injected to separate the transversalis fascia from the transversus muscle. Studies have demonstrated that this intervention blocks the proximal branches of T12 and L1 and to a lesser extent T11 in the plane between the transversus abdominis muscle and the transversalis fascia. Since its initial description, ultrasound (US)-guided TFPB has been explored in many randomized controlled trials for patients undergoing iliac crest bone harvesting, lower segment caesarean section (LSCS), inguinal hernia repair and hip surgeries.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. American society of anesthesiologists (ASA) class I and II. 2. Age ≥ 18 and ≤ 65 Years. 3. Cancer patients for inguinal lymph node dissection. 4. Body mass index (BMI): \> 20 kg/m2 and \< 40 kg/m2. Exclusion Criteria: 1. Patient refusal. 2. Local infection at the puncture site. 3. Coagulopathies with platelets count below 50,000 or an INR\>1.6. 4. Unstable cardiovascular disease. 5. History of psychiatric and cognitive disorders. 6. Patients allergic to medication used.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Cancer Institute Cairo University Cairo Egypt Recruiting

More National Cancer Institute, Egypt trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07331129 on ClinicalTrials.gov ↗ ← All trials in Egypt